The TAPUR study is a clinical trial that aims to improve our understanding of how commercially available anti-cancer drugs perform on a broader range of cancers, by matching the drugs to tumors with specific genomic mutations that the drugs are designed to target.
Accepting new patients
Note: This is only a partial list of eligibility criteria.
Generally speaking, qualifying participants must:
Accepting new patients
Learn more at
Principal Investigator(s)